But in HER-2-negative breast cancer MDA-MB-231 cells, the difference in Compound C pre-treated group and aspirin-alone treated group was not significant (Supplementary Figure 1D-E), and we found distinct lipid droplets distribution and cellular morphological changes. The gene discussed is ERBB2; the disease is breast cancer.